TEL AVIV, Israel — Novel Concepts Medical (NCM) is delighted to announce the groundbreaking results of its plant-based cure, which has interrupted the interaction between the SARS CoV-2 B1.1.529 Omicron spike RBD and the ACE2 protein, which is necessary to allow viral entry to human cells.
- Earlier testing demonstrated the ability to disrupt the interaction between the SARS-CoV-2 spike and ACE2 receptor, which is a therapeutic target for COVID-19. Disruption of this interaction will prevent viral entry into cells
- The second test demonstrated the ability to disrupt the TMPRSS2, which represents an additional therapeutic target for COVID-19.
- The third test demonstrated anti-viral activity in cell culture.
The testing methodology was devised by Dr. Rachel R. Alkalay, who is the inventor of these formulations and the founder of the company.
The testing, led by Tracey Campbell, PhD, was carried out by the Centre for Microbial Chemical Biology at the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University in Ontario, Canada.
The testing program concluded: “The NCM formulations act on multiple targets required for SARS CoV-2 infection. This has been demonstrated by in vitro enzyme testing and cell culture assays with a surrogate human coronavirus. This data suggests that these formulations are potential candidates for treatment of SARS CoV-2 infections.”
Dr. Alkalay said that her invention is unique because it is the first in the world to decompose the attachment of sugar residues to proteins in the SARS-CoV-2 spike glycoproteins, which play essential roles in the virus’s attachment, fusion, and entry into host cells. The treatment can STOP OMICRON and other mutations.
The company is now ready to offer emergency clinical testing anywhere in the world after early case studies conducted in Israel have demonstrated recovery within 48 hours. Specifically, all volunteers with positive PCR tests had negative PCR tests within 48 hours of taking NCM’s formulations, with no side effects. These case studies also demonstrated significant improvement in a number of Long COVID-19 symptoms, including fever, coughing, shortness of breath, headaches, sore throat, diarrhea, nausea, vomiting, muscles plain, fatigue, loss of taste and smell, memory loss, dizziness, and lack of focus.
NCM is now offering to sell its know-how to governments around the world to collaborate on emergency use authorization. For more information about the company, its lab results, or its plant- based treatment, please contact Dr. Alkalay via email at email@example.com.